Diseases, Conditions, Syndromes

WHO halts hydroxychloroquine trials on COVID-19 patients

The World Health Organization decided Wednesday to halt trials of hydroxychloroquine as a potential treatment for hospitalised COVID-19 patients, finding it did not reduce the mortality rate.

Medications

Side effects seen with use of chloroquine against COVID-19

(HealthDay)—The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision. Sahlgrenska University ...

Diseases, Conditions, Syndromes

US regulator approves limited use of malaria drugs for virus

A limited emergency-use authorization for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients.

page 3 from 11